Fenwick & West has advised Attovia Therapeutics. Cooley LLP has advised the underwriters. Attovia Therapeutics, a clinical-stage biopharmaceutical company, has announced the pricing of its upsized...
Attovia Therapeutics Launches Upsized $289 Million Initial Public Offering
$1.7 Billion Investment Announced for Bloom Energy Fuel Cell Powered AI Data Center
Paul Hastings LLP has advised MUFG Bank Ltd. as lead arranger and administrative agent. A $1.7 billion project investment has been announced for the deployment of...
Scribe Therapeutics Completes $155.51 Million Initial Public Offering and Private Placement
Fenwick has advised Scribe Therapeutics. Latham & Watkins has advised the underwriters. Scribe Therapeutics Inc., a clinical-stage biotechnology company specializing in in vivo CRISPR technologies, has...
Remix Therapeutics and Passage Bio Announce Merger and $100 Million Private Placement
Latham & Watkins LLP has advised Remix Therapeutics. Fenwick & West LLP has advised Passage Bio. Cooley LLP has advised Goldman Sachs & Co. LLC, Jefferies...
Merger Agreement Between Treeline Biosciences and Standard BioTools
Freshfields LLP and Richards, Layton & Finger, P.A. have advised Standard BioTools. Fenwick & West LLP has represented Treeline Biosciences. Treeline Biosciences and Standard BioTools Inc....
Servier to Acquire Day One Biopharmaceuticals in $2.5 Billion Transaction
Baker McKenzie has advised Servier, and Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One on IP matters related...
Heelstone Renewable Energy Secures $200 Million Credit Facility for Expansion
Paul Hastings LLP has advised Deutsche Bank AG as sole lead arranger. Heelstone Renewable Energy has secured a $200 million senior secured corporate credit facility, with...
BioAge Labs Completes $115 Million Upsized Public Offering
Fenwick & West has advised BioAge Labs, Inc. Cooley LLP has represented the underwriters. BioAge Labs, Inc., a clinical-stage biopharmaceutical company (Nasdaq: BIOA), has completed an...
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in Transaction Valued Up to $285 Million
Wilmer Cutler Pickering Hale and Dorr has advised Mersana Therapeutics. Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One...
BioAge Labs’ $238 Million Upsized Initial Public Offering
Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
Eli Lilly’s $3.2 Billion Acquisition of Morphic Holdings
Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
Stoke Therapeutics’ $125 Million Upsized Common Stock Offering
Fenwick & West advised Stoke Therapeutics on the offering, Wilson Sonsini Goodrich & Rosati advised Stoke on IP matters and Davis Polk & Wardwell advised the...